Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Leukemia & Lymphoma
|
September 24, 2016
Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy
Daniel Medina, Kevin David, Yong Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies
David A Rizzieri, Eric Feldman, John F Dipersio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2007
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma
Stephen M Ansell, Steven M Horwitz, Andreas Engert, et al.
Clinical Transplantation
|
March 4, 2017
Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation
Elan Gorshein, Catherine Wei, Susan Ambrosy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2015
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
Michael Andreeff, Kevin R Kelly, Karen Yee, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 21, 2018
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma
Victor Yazbeck, Danielle Shafer, Edward B Perkins, et al.
British Journal of Haematology
|
August 4, 2017
Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis
Abraham S Kanate, Alyssa DiGilio, Kwang W Ahn, et al.
Bone Marrow Transplantation
|
May 21, 2021
Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation
Mary-Elizabeth Percival, Hai-Lin Wang, Mei-Jie Zhang, et al.
Bone Marrow Transplantation
|
April 17, 2021
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation
Mary-Elizabeth Percival, Hai-Lin Wang, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 21, 2020
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
Annie Im, Armin Rashidi, Tao Wang, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Leukemia & Lymphoma
|
September 24, 2016
Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy
Daniel Medina, Kevin David, Yong Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies
David A Rizzieri, Eric Feldman, John F Dipersio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2007
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma
Stephen M Ansell, Steven M Horwitz, Andreas Engert, et al.
Clinical Transplantation
|
March 4, 2017
Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation
Elan Gorshein, Catherine Wei, Susan Ambrosy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2015
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
Michael Andreeff, Kevin R Kelly, Karen Yee, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 21, 2018
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma
Victor Yazbeck, Danielle Shafer, Edward B Perkins, et al.
British Journal of Haematology
|
August 4, 2017
Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis
Abraham S Kanate, Alyssa DiGilio, Kwang W Ahn, et al.
Bone Marrow Transplantation
|
May 21, 2021
Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation
Mary-Elizabeth Percival, Hai-Lin Wang, Mei-Jie Zhang, et al.
Bone Marrow Transplantation
|
April 17, 2021
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation
Mary-Elizabeth Percival, Hai-Lin Wang, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 21, 2020
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
Annie Im, Armin Rashidi, Tao Wang, et al.
Page
of 3